Repeated very small doses of the magic-mushroom compound, too small to feel, used for mood, focus, and balance. Personal reports are abundant but tightly controlled studies struggle to show benefit beyond expectation, so evidence stays low. Everyday side effects are mild and brief; the main unsettled concern is gradual heart-valve strain from long-term use. (Full Review)

Protocol

Dose

0.1–0.3 g dried

Sub-perceptual; ~one-tenth of a recreational dose

Schedule

Day on, days off

Fadiman protocol or Stamets stack; user-originated, not evidence-validated

Timing

Morning

Single dose; later dosing can disrupt sleep

Time to effect

Acute effects

Same day

Mood and cognitive shifts felt on the dosing day

Cumulative benefit

Over weeks

Claimed with repeated dosing, but controlled evidence is weak

Benefits

Low: Improved mood, reduced mild depression and anxiety; enhanced creativity and cognitive flexibility

Speculative: Cellular and longevity-related effects; increased sense of connectedness and wellbeing; improved focus and reduced stimulant reliance; chronic pain relief

Contraindications

Personal or family history of psychotic disorders (schizophrenia, bipolar I)

Significant valvular heart disease

Pregnancy or breastfeeding

Concurrent MAOIs

Key Interactions

Antidepressants (SSRIs, SNRIs)

Other serotonergic agents (triptans, tramadol, lithium, 5-HTP, St. John's wort)

OTC medications (dextromethorphan, St. John's wort)

Serotonergic or neuroactive supplements (5-HTP, L-tryptophan, St. John's wort, SAMe)

Full-dose psychedelic therapy or stimulants

Risk & Side Effects

Medium: Acute physiological and psychological side effects; cognitive control impairment

Low: Worsening or triggering of psychiatric symptoms

Speculative: Cardiac valve fibrosis from chronic 5-HT2B activation; unknown long-term and tolerance effects

Monitoring

Marker	Target	Why
Blood pressure	~110–125 / 70–80 mmHg	Microdoses transiently raise it
Resting heart rate	50–70 bpm	Transient increases occur acutely
Echocardiogram (valve assessment)	No valvular regurgitation or thickening	Screens for the theoretical 5-HT2B valve risk with long-term use

Cadence: Blood pressure at baseline, after the first 1–2 weeks, then monthly during any extended cycle; echocardiogram only for prolonged, repeated use on clinician advice

Qualitative Assessment

Stable or improved day-to-day mood without increased anxiety
Subjective sense of focus and emotional balance, weighed honestly against expectation
Sleep quality maintained (no dosing-related disruption)
Absence of acute side effects such as headache, restlessness, or palpitations

Microdosing Psilocybin for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment